US Stock MarketDetailed Quotes

ELAN Elanco Animal Health

Watchlist
  • 13.400
  • -0.040-0.30%
Close Nov 21 16:00 ET
  • 13.710
  • +0.310+2.31%
Post 16:16 ET
6.62BMarket Cap32.68P/E (TTM)

About Elanco Animal Health Company

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.

Company Profile

SymbolELAN
Company NameElanco Animal Health
Listing DateSep 20, 2018
Issue Price24.00
Founded1954
CEOMr. Jeffrey N. Simmons
MarketNYSE
Employees9800
Fiscal Year Ends12-31
Address2500 Innovation Way
CityGreenfield
ProvinceIndiana
CountryUnited States of America
Zip Code46140
Phone1-877-352-6261

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey N. Simmons
  • President, Chief Executive Officer and Director
  • 13.66M
  • James M. Meer
  • Senior Vice President and Chief Accounting Officer
  • --
  • Todd S. Young
  • Executive Vice President and Chief Financial Officer
  • 3.73M
  • David S. Kinard
  • Executive Vice President, Human Resources, Corporate Affairs and Administration
  • --
  • Grace McArdle
  • Executive Vice President, Manufacturing and Quality
  • --
  • Rajeev A. Modi
  • Executive Vice President, U.S. Pet Health and Global Digital Transformation
  • --
  • Jose Manuel Correia de Simas
  • Executive Vice President, U.S. Farm Animal Business
  • --
  • Shiv O'Neill
  • Executive Vice President, General Counsel and Corporate Secretary
  • --
  • Ramiro Martin Cabral
  • Executive Vice President and President of Elanco International
  • 2.65M
  • Ellen de Brabander, PhD
  • Executive Vice President, Innovation and Regulatory Affairs
  • 3.68M
  • Timothy J. Bettington
  • Executive Vice President, Corporate Strategy and Market Development
  • 2.05M
  • R. David Hoover
  • Chairman of the Board
  • 496.01K
  • Dr. Stacey Ma, PhD
  • Director
  • --
  • William F. Doyle
  • Independent Director
  • 330.01K
  • Kirk McDonald
  • Independent Director
  • 330.01K
  • Art A. Garcia
  • Independent Director
  • 330.01K
  • Dr. Deborah T. Kochevar
  • Independent Director
  • 346.01K
  • Paul S. Herendeen
  • Independent Director
  • 330.01K
  • Kathy V. Turner
  • Independent Director
  • --
  • Lawrence E. Kurzius
  • Independent Director
  • 350.01K
  • John P. Bilbrey
  • Independent Director
  • 346.01K
  • Kapila Kapur Anand
  • Independent Director
  • 355.01K
  • Michael J. Harrington
  • Independent Director
  • 330.01K
  • Dr. Denise Vera Scots-Knight, PhD
  • Independent Director
  • 330.01K
  • Craig Wallace
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data